US 12,201,557 B2
Drug eluting ocular implant and method of treating an ocular disorder
David S. Haffner, Mission Viejo, CA (US); Kenneth M. Curry, Oceanside, CA (US); Harold A. Heitzmann, Irvine, CA (US); and David Applegate, Laguna Hills, CA (US)
Assigned to Dose Medical Corporation, Aliso Viejo, CA (US)
Filed by Dose Medical Corporation, San Clemente, CA (US)
Filed on Nov. 30, 2022, as Appl. No. 18/060,126.
Application 18/060,126 is a continuation of application No. 17/219,102, filed on Mar. 31, 2021.
Application 17/219,102 is a continuation of application No. 15/422,384, filed on Feb. 1, 2017, abandoned.
Application 15/422,384 is a continuation of application No. 13/321,144, abandoned, previously published as PCT/US2010/035319, filed on May 18, 2010.
Claims priority of provisional application 61/264,604, filed on Nov. 25, 2009.
Claims priority of provisional application 61/264,594, filed on Nov. 25, 2009.
Claims priority of provisional application 61/264,615, filed on Nov. 25, 2009.
Claims priority of provisional application 61/220,527, filed on Jun. 25, 2009.
Claims priority of provisional application 61/179,332, filed on May 18, 2009.
Prior Publication US 2023/0090539 A1, Mar. 23, 2023
Int. Cl. A61F 9/007 (2006.01); A61F 9/00 (2006.01); A61K 9/00 (2006.01)
CPC A61F 9/0017 (2013.01) [A61F 9/00781 (2013.01); A61K 9/0051 (2013.01); A61F 2210/0004 (2013.01); A61F 2250/0068 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method of treating an ocular disorder, comprising:
inserting an implant into an eye, the implant comprising:
an outer shell defining an interior space, the outer shell having a proximal end and a closed distal end;
a permeable or semi-permeable membrane positioned at or near the proximal end of the outer shell;
a cap comprising an orifice and securing the permeable or semi-permeable membrane to the outer shell of the implant;
a retention protrusion extending from the closed distal end; and
at least one drug within the interior space, wherein the implant is configured to elute the at least one drug through the orifice of the cap; and
anchoring the retention protrusion of the implant to a sclera of the eye.